These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7815285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies.
    Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, Oliff L, Schlag P.
    Cancer Res; 1990 Sep 15; 50(18):5790-4. PubMed ID: 2118420
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy.
    Pestieau SR, Schnake KJ, Stuart OA, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2001 Mar 15; 47(3):269-76. PubMed ID: 11320672
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].
    Hribaschek A, Pross M, Ridwelski K, Meyer F, Fenske A, Krüger S, Lippert H.
    Zentralbl Chir; 2004 Aug 15; 129(4):328-34. PubMed ID: 15354258
    [Abstract] [Full Text] [Related]

  • 10. [Large volume intraperitoneal chemotherapy as treatment for the peritoneal carcinomatosis from gastric cancer].
    Yamauchi M, Ito A, Kodera Y, Kondo K, Nakahara H, Nagai S, Kuzuya T, Satta T, Ito K, Takagi H.
    Gan To Kagaku Ryoho; 1992 Apr 15; 19(4):463-8. PubMed ID: 1558395
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetic study of postoperative peritoneal infusion with large bulk heated hypotonic 5-fluorouracil fluid for prevention of recurrence and hepatic metastasis of gastric cancer].
    Lin AD, Sun HY, Qu MW, Wang FJ, Wang JY, Li ZJ.
    Ai Zheng; 2002 Apr 15; 21(4):424-9. PubMed ID: 12452026
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration.
    Sugarbaker PH, Stuart OA, Vidal-Jove J, Pessagno AM, DeBruijn EA.
    Cancer Treat Res; 1996 Apr 15; 82():41-52. PubMed ID: 8849942
    [Abstract] [Full Text] [Related]

  • 14. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
    Noh SH, Yoo CH, Chung HC, Roh JK, Shin DW, Min JS.
    Oncology; 2001 Apr 15; 60(1):24-30. PubMed ID: 11150904
    [Abstract] [Full Text] [Related]

  • 15. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH.
    Eur J Surg Oncol; 2001 Apr 15; 27(3):239-43. PubMed ID: 11373099
    [Abstract] [Full Text] [Related]

  • 16. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
    Shimizu T, Sonoda H, Murata S, Takebayashi K, Ohta H, Miyake T, Mekata E, Shiomi H, Naka S, Tani T.
    Eur J Surg Oncol; 2014 May 15; 40(5):521-528. PubMed ID: 24388411
    [Abstract] [Full Text] [Related]

  • 17. Continuous hyperthermic peritoneal perfusion for peritoneal carcinomatosis.
    Chung YC, Huang MT, Chang CN, Huang TW.
    J Formos Med Assoc; 1996 Feb 15; 95(2):138-43. PubMed ID: 9064002
    [Abstract] [Full Text] [Related]

  • 18. Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer.
    Schilsky RL, Choi KE, Grayhack J, Grimmer D, Guarnieri C, Fullem L.
    J Clin Oncol; 1990 Dec 15; 8(12):2054-61. PubMed ID: 2230897
    [Abstract] [Full Text] [Related]

  • 19. [Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
    Yano M, Tsujinaka T, Shiozaki H, Inoue M, Doki Y, Taniguchi M, Murata A, Monden M.
    Gan To Kagaku Ryoho; 1998 Jan 15; 25(1):139-42. PubMed ID: 9464342
    [No Abstract] [Full Text] [Related]

  • 20. Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis.
    Van der Speeten K, Stuart OA, Chang D, Mahteme H, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2011 Jul 15; 68(1):147-56. PubMed ID: 20857115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.